Yumin Hu

4.8k citations

76 papers · 3.8k indexed · h-index 33

Impact in

Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Mitochondrial Function and Pathology
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Genomics, phytochemicals, and oxidative stress
- ATP Synthase and ATPases Research
- RNA modifications and cancer

Papers in ⓘ

Cancer Research 24
- Cancer, Hypoxia, and Metabolism 20
Toxicology 3

Co-authors: Peng Huang (52 shared papers)Shijun Wen (34 shared papers)Hélène Pelicano (6 shared papers)Weiqin Lu (5 shared papers)Wenhua Lu (27 shared papers)Jérôme Alexandre (1 shared paper)Li Feng (2 shared papers)Bingling Luo (13 shared papers)
Journals: Cancer Letters (4 papers)Organic Letters (4 papers)Blood (4 papers)Nature Communications (3 papers)International Journal of Oncology (3 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Yumin Hu

76 papers receiving 3.8k citations

Peers

Countries citing papers authored by Yumin Hu

Since Specialization

Citations

This map shows the geographic impact of Yumin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Hu more than expected).

Fields of papers citing papers by Yumin Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Hu. The network helps show where Yumin Hu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yumin Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yumin Hu Line = papers co-authored together Yumin Hu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism The Journal of Cell Biology ·Hélène Pelicano, Rui‐Hua Xu, Min Du, Li Feng, Ryohei Sasaki, Jennifer S. Carew, Yumin Hu, Latha Ramdas, Limei Hu, Michael J. Keating, Wei Zhang, William Plunkett, Peng Huang	2006	319
2	Novel Action of Paclitaxel against Cancer Cells: Bystander Effect Mediated by Reactive Oxygen Species Cancer Research ·Jérôme Alexandre, Yumin Hu, Weiqin Lu, Hélène Pelicano, Peng Huang	2007	314
3	K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis Cell Research ·Yumin Hu, Weiqin Lu, Gang Chen, Peng Wang, Zhao Chen, Yan Zhou, Marcia A. Ogasawara, Dunyaporn Trachootham, Feng Li, Hélène Pelicano, Paul J. Chiao, Michael J. Keating, Guillermo Garcia‐Manero, Peng Huang	2011	245
4	Mitochondrial Manganese-Superoxide Dismutase Expression in Ovarian Cancer Journal of Biological Chemistry ·Yumin Hu, Daniel Rosen, Yan Zhou, Li Feng, Gong Yang, Jinsong Liu, Peng Huang	2005	234
5	Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism Cancer Research ·Hélène Pelicano, Weiqin Lu, Yan Zhou, Wan Zhang, Zhao Chen, Yumin Hu, Peng Huang	2009	154
6	Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism Cancer Letters ·Ming-zhe Ma, Kevin G. Chen, Peng Wang, Wen-Hua Lu, Chao-feng Zhu, Ming Song, Jing Yang, Shijun Wen, Rui‐Hua Xu, Yumin Hu, Peng Huang	2015	151
7	Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy PLoS Biology ·Weiqin Lu, Yumin Hu, Gang Chen, Chen Zhao, Hui Zhang, Feng Wang, Feng Li, Hélène Pelicano, Hua Wang, Michael J. Keating, Jinsong Liu, Wallace L. McKeehan, Huamin Wang, Yongde Luo, Peng Huang	2012	125
8	Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome Journal of Clinical Oncology ·Guillermo Garcia‐Manero, Francesco Paolo Tambaro, N. Bekele, Hui Yang, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Tapan M. Kadia, Marina Konopleva, Stefan Faderl, Jörge E. Cortes, Mark Brandt, Yumin Hu, Deborah McCue, Willie Newsome, Sherry R. Pierce, Marcos de Lima, Hagop M. Kantarjian	2012	124
9	Hypersensitization of Tumor Cells to Glycolytic Inhibitors Biochemistry ·Hongtan Liu, Yumin Hu, Niramol Savaraj, Waldemar Priebe, Théodore J. Lampidis	2001	120
10	Mild Cu(I)-Catalyzed Cascade Reaction of Cyclic Diaryliodoniums, Sodium Azide, and Alkynes: Efficient Synthesis of Triazolophenanthridines Organic Letters ·Zhenquan Liu, Daqian Zhu, Bingling Luo, Naiyuan Zhang, Qi Liu, Yumin Hu, Rongbiao Pi, Peng Huang, Shijun Wen	2014	102
11	Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells Cell Death and Disease ·Jiankang Wang, Bingling Luo, Xiaobing Li, Wenhua Lu, Jing Yang, Yumin Hu, Peng Huang, Shijun Wen	2017	100
12	Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer Oncotarget ·Peng Wang, Chao-feng Zhu, Ming-zhe Ma, Gang Chen, Ming Song, Zhao-Lei Zeng, Wen-Hua Lu, Jing Yang, Shijun Wen, Paul J. Chiao, Yumin Hu, Peng Huang	2015	92
13	Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate Blood ·Yumin Hu, Weiqin Lu, Gang Chen, Hui Zhang, Yu Jia, Yue Wei, Hui Yang, Wan Zhang, Warren Fiskus, Kapil N. Bhalla, Michael J. Keating, Peng Huang, Guillermo Garcia‐Manero	2010	86
14	Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling Molecular Cancer ·Jianwei Liao, Panpan Liu, Guoxin Hou, Jiajia Shao, Jing Yang, Kai‐Yan Liu, Wenhua Lu, Shijun Wen, Yumin Hu, Peng Huang	2017	83
15	Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis Cell Death and Disease ·Guoxin Hou, Panpan Liu, Shengyi Zhang, Mengqi Yang, Jianwei Liao, Jing Yang, Yumin Hu, Wen-Qi Jiang, Shijun Wen, Peng Huang	2018	81
16	Inhibition of Mitochondrial Respiration and Rapid Depletion of Mitochondrial Glutathione by β-Phenethyl Isothiocyanate: Mechanisms for Anti-Leukemia Activity Antioxidants and Redox Signaling ·Gang Chen, Zhao Chen, Yumin Hu, Peng Huang	2011	72
17	Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester Journal of Bioenergetics and Biomembranes ·Zhenjie Tang, Shuqiang Yuan, Yumin Hu, Hui Zhang, Wenjing Wu, Zhao-Lei Zeng, Jing Yang, Jing‐Ping Yun, Rui‐Hua Xu, Peng Huang	2012	70
18	Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression International Journal of Oncology ·Kai‐Yan Liu, Zhenjie Tang, Amin Huang, Ping Chen, Panpan Liu, Jing Yang, Wenhua Lu, Jianwei Liao, Yicheng Sun, Shijun Wen, Yumin Hu, Peng Huang	2016	67
19	Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma Journal of Medicinal Chemistry ·Yalin Tu, Yameng Sun, Shuang Qiao, Yao Luo, Panpan Liu, Zhong‐Xing Jiang, Yumin Hu, Zifeng Wang, Peng Huang, Shijun Wen	2021	67
20	Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling Redox Biology ·Christophe Glorieux, Xiaojun Xia, Yong-Qiao He, Yumin Hu, Kelly Cremer, Annie Robert, Junchen Liu, Fen Wang, Jianhua Ling, Paul J. Chiao, Peng Huang	2020	60

About Yumin Hu

Yumin Hu is a scholar working on Cancer Research, Toxicology, Hematology, Molecular Biology and Organic Chemistry, having authored 76 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), Histone Deacetylase Inhibitors Research (10 papers), Acute Myeloid Leukemia Research (8 papers), Catalytic C–H Functionalization Methods (8 papers), Mitochondrial Function and Pathology (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Synthesis and Catalytic Reactions (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.4k citations), Oncology (630 citations), Hematology (219 citations) and Organic Chemistry (560 citations). Yumin Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Peng Huang, Shijun Wen, Hélène Pelicano, Weiqin Lu, Wenhua Lu, Jérôme Alexandre, Li Feng, Bingling Luo, Michael J. Keating and Jing Yang. Their work appears in journals such as Cancer Letters, Organic Letters, Blood, Nature Communications and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact